219 related articles for article (PubMed ID: 32849622)
21. Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates.
Ruiz MJ; Salido J; Abusamra L; Ghiglione Y; Cevallos C; Damilano G; Rodriguez AM; Trifone C; Laufer N; Giavedoni LD; Sued O; Salomón H; Gherardi MM; Turk G
EBioMedicine; 2017 Dec; 26():25-37. PubMed ID: 29129698
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
23. Changes of blood CD16/CD56 (NK) and HLA-DR/CD3-positive lymphocyte amounts in HIV-infected children, as related to clinical progression and p24-antigen/p24-antibody presence.
Voiculescu C; Avramescu C; Balasoiu M; Turculeanu A; Radu E
FEMS Immunol Med Microbiol; 1994 Sep; 9(3):217-21. PubMed ID: 7529081
[TBL] [Abstract][Full Text] [Related]
24. Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement.
Lofano G; Gorman MJ; Yousif AS; Yu WH; Fox JM; Dugast AS; Ackerman ME; Suscovich TJ; Weiner J; Barouch D; Streeck H; Little S; Smith D; Richman D; Lauffenburger D; Walker BD; Diamond MS; Alter G
Sci Immunol; 2018 Aug; 3(26):. PubMed ID: 30120121
[TBL] [Abstract][Full Text] [Related]
25. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
Front Immunol; 2018; 9():3163. PubMed ID: 30697215
[TBL] [Abstract][Full Text] [Related]
26. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.
Hogervorst E; Jurriaans S; de Wolf F; van Wijk A; Wiersma A; Valk M; Roos M; van Gemen B; Coutinho R; Miedema F
J Infect Dis; 1995 Apr; 171(4):811-21. PubMed ID: 7706807
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
[TBL] [Abstract][Full Text] [Related]
28. Clonal dominance: cause for a limited and failing immune response to HIV-1 infection and vaccination.
Kohler H; Goudsmit J; Nara P
J Acquir Immune Defic Syndr (1988); 1992; 5(11):1158-68. PubMed ID: 1403647
[TBL] [Abstract][Full Text] [Related]
29. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
[TBL] [Abstract][Full Text] [Related]
30. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.
Brown EP; Dowell KG; Boesch AW; Normandin E; Mahan AE; Chu T; Barouch DH; Bailey-Kellogg C; Alter G; Ackerman ME
J Immunol Methods; 2017 Apr; 443():33-44. PubMed ID: 28163018
[TBL] [Abstract][Full Text] [Related]
31. Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy.
Ouyang Y; Yin Q; Li W; Li Z; Kong D; Wu Y; Hong K; Xing H; Shao Y; Jiang S; Ying T; Ma L
Sci Rep; 2017 Jul; 7(1):6222. PubMed ID: 28740221
[TBL] [Abstract][Full Text] [Related]
32. HIV-specific antibody immunity mediated through NK cells and monocytes.
Kramski M; Parsons MS; Stratov I; Kent SJ
Curr HIV Res; 2013 Jul; 11(5):388-406. PubMed ID: 24191935
[TBL] [Abstract][Full Text] [Related]
33. IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation.
Forthal DN; Landucci G; Ding H; Kappes JC; Wang A; Thung I; Phan T
AIDS; 2011 Nov; 25(17):2099-104. PubMed ID: 21832933
[TBL] [Abstract][Full Text] [Related]
34. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.
Richardson SI; Chung AW; Natarajan H; Mabvakure B; Mkhize NN; Garrett N; Abdool Karim S; Moore PL; Ackerman ME; Alter G; Morris L
PLoS Pathog; 2018 Apr; 14(4):e1006987. PubMed ID: 29630668
[TBL] [Abstract][Full Text] [Related]
35. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
36. Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers.
Lai JI; Licht AF; Dugast AS; Suscovich T; Choi I; Bailey-Kellogg C; Alter G; Ackerman ME
J Virol; 2014 Mar; 88(5):2799-809. PubMed ID: 24352471
[TBL] [Abstract][Full Text] [Related]
37. Comparative humoral responses to HIV-1 p24gag and gp120env in subjects from East Africa and the UK.
Kaleebu P; Cheingsong-Popov R; Callow D; Katabira E; Mubiru F; Biryahwaho B; Sempala S; Gilks C; Brindle R; Were JB
AIDS; 1991 Aug; 5(8):1015-9. PubMed ID: 1777160
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of human immunodeficiency virus type 1 antibody reactivity by western immunoblots: evaluation of relative antibody levels in seropositive individuals and mothers.
Geffin RB; Lai SH; Hutto C; Scott GB; Scott WA; Master M; Parks WP
J Infect Dis; 1992 Jan; 165(1):111-8. PubMed ID: 1727880
[TBL] [Abstract][Full Text] [Related]
39. Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41.
Duchemin M; Tudor D; Cottignies-Calamarte A; Bomsel M
Front Immunol; 2020; 11():1141. PubMed ID: 32582208
[TBL] [Abstract][Full Text] [Related]
40. Correlation of serum antigen and antibody concentration with clinical features in HIV infection.
Ellaurie M; Rubinstein A
Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
